VJHemOnc is committed to improving our service to you

EHA 2020 | R/R DLBCL: impact of allo-HSCT conditioning on patient survival

VJHemOnc is committed to improving our service to you

Nilanjan Ghosh

Nilanjan Ghosh MD, PhD, of Levine Cancer Institute, Charlotte, NC, explores the impact of conditioning prior to allogeneic hematopoietic stem cell transplants (allo-HSCT) on survival for relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter